PROCEPT BioRobotics Hits Day Low of $22.49 Amid Price Pressure

PROCEPT BioRobotics Corp., a small-cap player in the Pharmaceuticals & Biotechnology sector, experienced a significant decline today, with its stock price dropping by 9.67%. The stock reached an intraday low of USD 22.49, reflecting ongoing challenges in its market performance. Over the past week, PROCEPT BioRobotics has seen a steep decline of 18.1%, and its one-month performance shows a decrease of 11.1%. The stock's year-to-date performance stands at a loss of 26.19%, while its one-year performance has plummeted by 61.7%. In comparison, the S&P 500 has shown a positive performance across these time frames, with a one-year gain of 26.39%. Key financial metrics indicate that the company is facing difficulties, including a notably low inventory turnover ratio of 1.7 times and a debtors turnover ratio of 3.67 times. Additionally, the operating profit for the latest quarter was reported at a loss of USD 30.87 million. With these figures, PROCEPT BioRobotics continues to navigate a challenging financial landscape.